Indications Continue to Expand for EGFR Targeted Therapies in Lung Cancer
Research into mutations in the gene encoding the epidermal growth factor receptor protein has revolutionized non–small cell lung cancer treatment in recent years, yet the science supporting targeting of this oncogene is still being elucidated.